sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Global Gene Therapy Market Growth (Status and Outlook) 2019-2024

Global Gene Therapy Market Growth (Status and Outlook) 2019-2024

Home / Categories / Healthcare
Global Gene Therapy Market Growth (Status and Outlook) 2019-2024
Global Gene Therapy Market Growth...
Report Code
RO1/109/1597

Publish Date
12/Feb/2019

Pages
115
PRICE
$ 3660/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 5490/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 7320/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
Gene therapy is an experimental treatment that involves introducing genetic material into a person?s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier known as a ?vector.? The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy.
Gene therapy is a method that involves introducing genetic material into a person?s cells to fight or prevent diseases. In recent decades of years, researchers are paying more and more attention on it. Until today, it is still in infancy. There are many bio-technology companies entered into this market and carry on related research and development.

These research companies are including Bluebird Bio, Sangamom, Spark Therapeutics, Dimension Therapeutics, Avalanche Bio, Celladon, Vical and Advantagene. Among them, the top 5 research companies occupied more than 85% market.

Generally, the research fees of companies are come from their collaboration partners. For example, Bayer Healthcare is the partner of Dimension Therapeutics. General, some products of these companies are in the period 3 of their pipeline.

In general, cancer diseases are still the largest application with market share over 65% in 2015. In addition, there are some companies are focus on rare diseases.


According to this study, over the next five years the Gene Therapy market will register a xx% CAGR in terms of revenue, the global market size will reach USD xx million by 2024, from USD xx million in 2019. In particular, this report presents the global revenue market share of key companies in Gene Therapy business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Gene Therapy market by product type, application, key companies and key regions.

This study considers the Gene Therapy value generated from the sales of the following segments-

Segmentation by product type- breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Ex vivo
In Vivo
Segmentation by application- breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Cancer
Monogenic
Infectious disease
Cardiovascular disease
Other

This report also splits the market by region- Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report- Breakdown data in in Chapter 3.
Bluebird Bio
Sangamo
Spark Therapeutics
Dimension Therapeutics
Avalanche Bio
Celladon
Vical Inc.
Advantagene

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Gene Therapy market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Gene Therapy market by identifying its various subsegments.
Focuses on the key global Gene Therapy players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Gene Therapy with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Gene Therapy submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com